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A point mutation in the cytoplasmic domain of the transferrin
receptor inhibits endocytosis
Elvira ALVAREZ, Nuiria GIRONES and Roger J. DAVIS
Department of Biochemistry, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester,
MA 01655, U.S.A.
The rate of receptor-mediated endocytosis of diferric 1251-transferrin by Chinese-hamster ovary cells expressing human
transferrin receptors was compared with the rate measured for cells expressing hamster transferrin receptors. It was
observed that the rate of endocytosis of the human transferrin receptor was significantly higher than that for the hamster
receptor. In order to examine the molecular basis for the difference between the observed rates of endocytosis, a cDNA
clone corresponding to the cytoplasmic domain of the hamster receptor was isolated. The predicted primary sequence of
the cytoplasmic domain of the hamster transferrin receptor is identical with that of the human receptor, except at
position 20, where a tyrosine residue in the human sequence is replaced with a cysteine residue. To test the hypothesis that
this structural change in the receptor is related to the difference in the rate of internalization, we used site-directed
mutagenesis to examine the effect of the replacement of tyrosine-20 with a cysteine residue in the human transferrin
receptor. It was observed that the substitution of tyrosine-20 with cysteine caused a 60% inhibition of the rate of iron
accumulation by cells incubated with [59Fe]diferric transferrin. No significant difference between the rate of internalization
of the mutant (cysteine-20) human receptor and the hamster receptor was observed. Thus the substitution of tyrosine-20
with a cysteine residue can account for the difference between the rate of endocytosis of the human and hamster transferrin
receptors.
INTRODUCTION
The cytoplasmic domain of the transferrin receptor has been
demonstrated to be required for the clustering of the receptors in
coated pits and subsequent endocytosis (Rothenberger et al.,
1987; lacopetta et al., 1988). A role for the cytoplasmic domain
has also been established for the endocytosis of the polymeric Ig
receptor (Mostov et al., 1986), the low-density-liproprotein
(LDL) receptor (Anderson et al., 1977; Davis et al., 1987a), and
the cation-independent mannose 6-phosphate receptor (Lobel
et al., 1989). Little is known about the structural information
that is present in the cytoplasmic domains of these receptors that
determines the sorting process during internalization. In the case
of the LDL receptor, tyrosine-807 has been reported to play an
important role in receptor-mediated endocytosis (Davis et al.,
1987a). Recently it has been reported that tyrosine-24 and
tyrosine-26 are required for the efficient endocytosis of the
cation-independent mannose 6-phosphate receptor (Lobel et al.,
1989). Furthermore, it has been demonstrated that the replace-
ment of cysteine-543 with a tyrosine residue in the influenza
haemagglutinin (HA) protein cytoplasmic tail allows this protein
to assemble into coated pits and undergo endocytosis (Lazarovits
& Roth, 1988), whereas the native protein is excluded from
plasma-membrane coated pits (Roth et al., 1986). Together these
studies suggest that a tyrosine residue in the cytoplasmic domain
of receptors may be part of a structure that is required for
clustering in coated pits.
The purpose of the experiments reported here was to obtain
evidence for a specific region of the transferrin receptor cyto-
plasmic domain that is required for endocytosis. The approach
that we took was to compare the structure and function of the
human and hamster transferrin receptors.
EXPERIMENTAL
Materials
Na1251, 35S-labelled dATP, [deoxyadenosine 5'-(a-[35S]thio)-
triphosphate], [y-32P]ATP and 59FeCl3 were from Amersham
International. Human transferrin was from Behring Diagnostics
and was saturated with iron as described by Davis & Czech
(1986). Diferric 1251-transferrin (5-7 Ci/g) and [69Fe]diferric trans-
ferrin (30-40 mCi/g) were prepared as described by Davis &
Czech (1986). The monoclonal antibody OKT9 was purified by
Protein A-Sepharose chromatography from the tissue-culture
supernatant of hybridoma cells obtained from the American
Type Culture Collection. Sequenase and Thermus aquaticus DNA
polymerase were obtained from United States Biochemical Corp.
and Perkin Elmer Cetus respectively. All other enzymes were
from Boehringer.
Tissue culture
CHO-KI cells and 3T3 LI pre-adipocytes were obtained from
the American Type Culture Collection. The isolation ofTF- cells
has been previously described (Alvarez et al., 1989). 3T3 LI pre-
adipocytes were maintained in Dulbecco's modified Eagle's
medium supplemented with 5% (v/v) calf serum. CHO and TF-
cells were maintained in Ham's F12 medium supplemented with
5 % (v/v) fetal-bovine serum (Gibco). Human transferrin recep-
tors were expressed in TF- cells by transfection of the cells using
the calcium phosphate method (Alvarez et al., 1989). Transfected
cells were selected by incubation with modified Eagle's medium
a supplemented with 500 nM-amethopterin, 0.25,uM-Fe(NO03
and 5 % dialysed fetal-bovine serum. Stable colonies were
obtained and were isolated by using cloning rings (Alvarez et at.,
1989).
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Polymerase chain reaction
The template used for the polymerase chain reaction was a
hamster cDNA library (Chin et al., 1984) obtained from Dr. G.
Gil (University of Massachusetts Medical School). The primers
used were 5'-GTAGCCA(C/A)TCAT(A/G)AATCCAAT-
CAAGAA-3'and5'-CGCTAGTGTTCTTCTGTGTGGCAG-
TTC-3'. The template (I ,ug) was mixed with the two primers
(100 pmol) in 10 mM-Tris (pH 8.3)/50 mM-KCI/ 1.5 mM-MgCl2/
200 gM-dATP/200 ,zM-dCTP/200 ,tM-dTTP/200 M-dGTP/
0.01 % (w/v) gelatin (final volume of 100 ,tl). The reaction
mixture was heated to 100 °C for 10 min and cooled to 68 °C for
O min. Thermus aquaticus DNA polymerase (2.5 units) was
added during the incubation at 68 'C. In all, 35 cycles of
amplification were then performed (denaturation, 1.5 min at
94 'C; annealing, 1.5 min at 50 'C; extension, 5 min at 68 °C).
The amplified DNA was phenol-extracted, ethanol-precipitated,
and analysed by polyacrylamide-gel electrophoresis. A 285 bp
amplified fragment was observed. The 285 bp DNA fragment
was eluted from the gel and cloned into M13mpl8 at the
restriction endonuclease SmaI site. Ten M 13 clones were picked
and sequenced using the ddNTP chain-termination method
(Sanger et al., 1977). The experiment was repeated twice. The
sequence of the 285 bp fragment was the same for all the clones
examined.
Plasmid construction
The human transferrin receptor cDNA (Kuhn et al., 1984;
McClelland et al., 1984) was obtained from Dr. F. Ruddle (Yale
University). A BamHI-HindIIl 0.9 kb fragment of the cDNA
(which contains the 5'-untranslated region and the coding region
for the cytoplasmic domain) was subcloned into M13mpl8 as
described by Davis & Meisner (1987). Site-directed mutagenesis
of tyrosine-20 was carried out as described by Zoller & Smith
(1984) using 18-mer oligonucleotides coding for cysteine (5'-
AACCGGGTACATGACAAT-3') and phenylalanine (5'-
AACCGGGATAATGACAAT-3'). Mutations were confirmed
by sequencing using 35S-labelled dATP, ddNTPs and Sequenase
(Sanger et al., 1977). Replicative-form DNA was isolated and the
cDNA fragment prepared by endonuclease digestion and
agarose-gel electrophoresis. This fragment was ligated to a
HindIII-BglI 1.9 kb fragment of the receptor cDNA that
contains the coding region for the C-terminal domain of the
receptor, and the full-length cDNA was isolated by agarose-gel
electrophoresis (Davis & Meisner, 1987). The full-length wild-
type and mutant cDNAs were then cloned into an expression
vector as described by Alvarez et al. (1989). This vector contains
the mouse dihydrofolate reductase gene as a selectable marker
and allows the expression of the transferrin receptor cDNA by
utilizing the simian-virus-40 early promoter and polyadenylation
signals. The correct orientation of the cDNAs cloned into the
expression vector was determined by digestion with restriction
endonucleases.
Binding of diferric '2II-transferrin to cell-surface receptors
Binding assays were performed on cells grown in 16 mm-
diameter wells. The cells were washed with serum-free
medium and incubated for 30 min at 37 'C in 30,uM bovine
serum albumin/ 120 mM-NaCl/6 mM-KCl/ 1.2 mM-MgCl2/ 1 mM-
CaCl2/10 mM-glucose/25 mM-Hepes, pH 7.4. The medium was
removed and rapidly replaced with medium at 4 'C. Diferric
125I-transferrin was added to the cells, which were incubated for
180 min at 4 'C. The monolayers were washed three times with
cold medium and solubilized with 900,u of IM-NaOH. Radio-
activity associated with the cells was quantified with a Beckman
y-radiation counter. Non-specific binding was estimated in
incubations with a 200-fold excess of unlabelled ligand.
Transferrin-receptor endocytosis
The endocytotic rate constant for transferrin-receptor
internalization was measured by the In/Sur method described by
Wiley & Cunningham (1982). The method involves the measure-
ment of the rate of intracellular accumulation of ligand under
conditions where the number of occupied cell-surface receptors is
constant and no release of accumulated ligand occurs. CHO cells
were incubated at 37 °C with 10 nm diferric 1251-transferrin. At
defined times the binding of the 125I-transferrin to the cells was
measured by rapidly washing the cell monolayers at 4 °C and
determining the associated radioactivity with a y-radiation
counter. Cell-surface and intracellularly bound 125I-transferrin
was determined by incubation of the cells for 3 min at 4 °C with
50 mM-NaCl/ 150 mM-glycine, pH 3.0. Intracellular 1251-trans-
ferrin was estimated by measurement of the cell-associated
radioactivity after acid washing (Haigler et al., 1980; Lamb et al.,
1983). Cell-surface-bound 1251-transferrin was estimated by sub-
traction of the intracellularly bound 1251-transferrin from the
total specific binding of 1251-transferrin to cell monolayers. Non-
specific binding of 1251-transferrin was estimated in incubations
containing a 200-fold excess of unlabelled ligand.
Transferrin-receptor recycling
The apparent first-order rate constant for the recycling of
transferrin receptors was estimated by measuring the rate of
recycling of 125I-transferrin as described previously (Alvarez
et al., 1989). CHO cells were seeded in 16 mm wells and grown to
a density of 5 x 104 cells per well. The cells were then incubated
with 10 nm diferric 1251-transferrin for 2 h at 37 'C. The medium
was removed and the cells were washed at 0 'C and subsequently
incubated for 3 min at 0 'C with 50 mM-NaCl/ 150 mM-glycine,
pH 3.0, to remove ligand bound to the cell surface (Haigler et al.,
1980; Lamb et al., 1983). Control experiments demonstrated that
the acid-washing procedure caused the dissociation of more than
950% of 1251-transferrin specifically bound to cell-surface recep-
tors (results not shown). To investigate the rate of recycling of
1251-transferrin, the cells were incubated with medium at 37 'C to
initiate the release of intracellular 125I-transferrin for defined
times. The radioactivity remaining associated with the cells was
measured with a radiation counter. The apparent first-order rate
constant for the release of 1251-transferrin was estimated by
using the computer program ENZFITTER (Elsevier Biosoft).
Previously, the rate of 125I-transferrin recycling has been de-
termined in experiments employing a pulse-chase procedure
without an acid wash (Davis et al., 1987b). The rates of recycling
of 1251-transferrin measured in experiments performed without
(Davis et al.,1987b) and with (Alvarez et al., 1989) an acid wash
are similar. We therefore conclude that the acid-washing pro-
cedure employed in the present study does not cause a marked
inhibition of the recycling of 1251I-transferrin.
Accumulation of 159Feldiferric transferrin
CHO cells were seeded in 16 mm wells and grown to a density
of 5 x 104 cells per well. The cells were washed with serum-free
medium and incubated for 30 min at 37 'C in 120 mM-NaCl/
6 mM-KCI/1.2 mM-MgCl2/l mM-CaCl2/25 mM-Hepes, pH 7.4
containing 30 /M bovine serum albumin. The cells were then
incubated for different times with 300 nM-[59Fe]diferric
transferrin at 37 'C. At defined times the cells were washed
rapidly at 4 °C, solubilized and the radioactivity associated with
the cells was measured with a liquid-scintillation counter as
described by Davis & Czech (1986).
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RESULTS
Human transferrin receptors were expressed in a CHO-KI
variant (clone TF-) that lacks endogenous transferrin receptors
(Alvarez et al., 1989). The first-order rate constant for the
endocytosis of the human receptor expressed in TF- cells was
measured to be 0.32 min-' (Table 1). This rate is similar to that
previously reported for the endocytosis ofthe transferrin receptor
in A431 human epidermoid-carcinoma cells, namely 0.33 min-'
(Davis et al., 1987b). In contrast with the rapid endocytosis of the
human transferrin receptor, the rate ofendocytosis ofthe hamster
transferrin receptor in CHO-KI cells was found to be significantly
slower (Table 1). These data indicate that the hamster transferrin
receptor is internalized less efficiently than the human receptor.
To examine the molecular basis for the lower rate of endo-
cytosis of the hamster transferrin receptor, a cDNA clone
corresponding to the cytoplasmic domain of the receptor was
isolated from a CHO-cell library. The sequence of the clone
obtained was very similar to the published sequence of the
human transferrin receptor (McClelland et al., 1984; Schneider
et al., 1984). Only two differences between the cDNA sequence
corresponding to the cytoplasmic domains of the human and
hamster receptors were observed. The first difference was found
at codon 8, where the human and hamster sequences were GCT
(Ala) and GCA (Ala) respectively. The second difference was
detected at codon 20, where TGT (Cys) was found in the hamster
cDNA in contrast with TAT (Tyr) in the human sequence. The
predicted amino acid sequence of the cytoplasmic domains of
the human and hamster transferrin receptors are presented in
Fig. 1.
There is a single amino acid difference between the primary
sequence of the cytoplasmic domains of the human and hamster
transferrin receptors at residue 20 (Fig. 1). As evidence has been
reported indicating that the cytoplasmic domain of the receptor
plays a role in endocytosis (Rothenberger et al., 1987; Iacopetta
et al., 1988), it is possible that this difference in sequence
accounts for the lower observed rate of internalization of the
hamster transferrin receptor compared with the human receptor.
To test this hypothesis, the effect of replacement of tyrosine-20 in
the human transferrin receptor with a cysteine residue was
examined using site-directed mutagenesis. In a control experiment
the effect of the replacement of tyrosine-20 with a phenylalanine
residue was investigated.
TF- cells expressing [Tyr20]-, [Cys20]- or [Phe20]-human trans-
ferrin receptors were isolated. Investigation of the binding
isotherm demonstrated that the Kd (mean+S.E.M.) for diferric
1251-transferrin was 0.88 + 0.09 nm ([Tyr20]-) 0.73+ 0.06 nm
([Cys20]-) and 0.81 + 0.16 nM ([Phe20]-). These data indicate that
1 .13
Human NH2 Met Met Asp Gln Ala Arg Ser Ala Phe Ser Asn Leu Phe
Mouse NH2 -
- - - - - - - - - - - -
Hamster NH2 - - - - - - - - - - - - _
Human
Mouse
Hamster
14 27
Gly Gly Glu Pro Leu Ser Tyr Thr Arg Phe Ser Leu Ala Arg
.
- Cys .- - - - .
28 41
Human Gln Val Asp Gly Asp Asn Ser His Val Glu Met Lys Leu Ala
Mouse
Hamster
42 55
HUMan Val Asp Glu Glu Glu Asn Ala Asp Asn Asn Thr Lys Ala Asn
Mouse Ala Met - - Ser
Hamster
56 61
Human Val Thr Lys Pro Lys Arg.
Mouse - Arg
Hamster
Fig. 1. Comparison of the primary sequence of the cytoplasmic domains of
the human, mouse and hamster transferrin receptors
The predicted primary sequence of the cytoplasmic domains of the
human, mouse and hamster transferrin receptors are presented. The
human and mouse receptor sequences were taken from Schneider
et al. (1984), McClelland et al. (1984), Stearne et al. (1985) and
Rothenberger et al. (1987). The hamster receptor sequence was
deduced from a partial cDNA clone that was obtained using
polymerase-chain-reaction amplification of a hamster cDNA library
(see the Experimental section).
the mutation of the cytoplasmic domain did not significantly
alter the affinity of the receptor for diferric 12.5-transferrin. The
function of the wild-type and mutant transferrin receptors were
characterized by examination of the rates of receptor endocytosis
and recycling. Table 1 shows that the rate of recycling of the
[Tyr20]-, [Phe21]- and [Cys20]-human transferrin receptors were
not significantly different. However, the rate of endocytosis of
the [Phew4]- and [Cys201-human transferrin receptors was sig-
nificantly lower than that observed for the wild-type [Tyr20]-
receptor (Table 1). Thus the substitution of tyrosine-20 with a
cysteine or a phenylalanine residue caused a diminution in the
rate of endocytosis without altering the rate of receptor recycling
(Table 1). These changes in the kinetic parameters for receptor
cycling were associated with an increase in the expression of the
mutant receptors at the cell surface compared with the wild-type
receptor (Table 2). To examine the significance of these changes
in receptor cycling, the accumulation of iron by cells incubated
with [59Fe]diferric transferrin was investigated. Fig. 2 shows that
the rate of iron uptake by the [Cys20]- and [Phe20]-human
Table 1. Summary of kinetic rate constants for transferrin-receptor
recycling
The first-order rate constants for the endocytosis and recycling of
the transferrin receptor were estimated from the rates of
internalization of diferric 'l25-transferrin and release of 125I-apo-
transferrin respectively. Results are means + S.D. for three separate
experiments.
Rate constant (min-i)
Species... Hamster Human Human Human
Receptor... [Cys20]- [Tyr20]- [Phe5i- [Cys50J-
Endocytosis~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Endocytosis
Recycling
Vol. 267
Table 2. Cell-surface expression of ITyr201-, IPhe201- and ICys20I-human
transferrin receptors
TF- cells expressing [Tyr20]-, IPhe2i]- and [Cys20]-human transferrin
receptors were incubated at 37 °C for 60 min with 10 nM-[1251]diferric
transferrin. The specific binding of .25I-transferrin to cell-surface
and intracellular receptors was measured as described in the Ex-
perimental section. Results are means+ S.D. for three separate
experiments.
Expression (%)
Mutant
Wild-type
Receptor... [Tyr20]- [Phe20]- ICys20]-
Cell surface 21.3 +2.1 30.7 +2.0 37.7+ 1.1
Intracellular 78.7+2.1 69.3 +2.0 62.3 + 1.0
0.24+0.014 0.32 + 0.023 0.25 + 0.015 0.23 + 0.029
0.137+0.005 0.085+0.003 0.10+0.024 0.11+0.016
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transferrin receptors was 38 and 62% of the rate measured for
the wild-type [Tyr20]receptor respectively.
DISCUSSION
It has been demonstrated that the cytoplasmic domain of the
transferrin receptor is required for the clustering of the receptor
into plasma-membrane coated pits and subsequent endocytosis.
As an initial approach to investigate whether a specific region of
the cytoplasmic domain is required for endocytosis, we have
compared the structure and function of the human and hamster
transferrin receptors. It was observed that the rate of endocytosis
of the human receptor expressed in CHO cells was similar to the
rate measured in A431 human epidermoid-carcinoma cells. By
contrast, the rate of endocytosis of the hamster receptor in CHO
cells was significantly lower than that of the human receptor. To
investigate the molecular basis for the low rate of endocytosis of
the hamster receptor, a cDNA clone corresponding to the
cytoplasmic domain of the hamster receptor was isolated from a
CHO-cell library. A single amino acid difference was found
between the predicted primary sequence of the cytoplasmic
domains of the human and hamster transferrin receptors
(Fig. 1). Residue 20 was tyrosine and cysteine in the human and
hamster receptors respectively. To test the hypothesis that this
structural change in the receptor is related to the difference in the
rate of internalization we used site-directed mutagenesis to
examine the effect of the replacement of tyrosine-20 with a
cysteine residue in the human transferrin receptor. The data
obtained demonstrate that the substitution of tyrosine-20 with a
cysteine residue can account for the difference between the rate
of endocytosis of the human and hamster transferrin receptors
(Table 1).
Previous studies have indicated a role for a tyrosine residue in
the cytoplasmic domain of the LDL receptor in the process of
endocytosis (Davis et al., 1987a). Substitution of tyrosine-807 in
the LDL receptor with a cysteine residue caused a 78% inhibition
of the internalization of 1251-LDL (Davis et al., 1987a). In the
present study, substitution of transferrin-receptor tyrosine-20
with a cysteine residue caused a 62% inhibition of the internal-
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Fig. 2. Accumulation of I59Feldiferric transferrin
TF- cells expressing [Tyr20]- (-), [Phe20]- (A), and [Cys2]- (v)
human transferrin receptors were incubated for different periods
with 300 nM-[59Fe]diferric transferrin. The cells were then washed
and the radioactivity associated with the cells was measured by using
a Beckman liquid-scintillation counter. In parallel experiments the
number of cell-surface binding sites for diferric .251-transferrin was
determined at 4 °C by Scatchard analysis of the binding isotherm
using the computer program LIGAND (Munson & Rodbard, 1980).
The results are presented as mol of [5"Fe]diferric transferrin accumu-
lated per mol of cell-surface receptors. Results are means + S.D. for
three separate experiments.
ization of [59Fe]diferric transferrin (Fig. 2). These data indicate
that the substitution of the tyrosine residue in the cytoplasmic
domains of these receptors with cysteine caused qualitatively
similar effects on endocytosis. By contrast, distinct effects of
substitution with phenylalanine were observed for the LDL and
transferrin receptors. Although the replacement of LDL-receptor
tyrosine-807 with phenylalanine had no significant effect on
endocytosis (Davis et al., 1987a), the substitution of transferrin-
receptor tyrosine-20 with phenylalanine caused an inhibition of
the internalization of diferric transferrin (Fig. 2). Studies with the
influenza HA protein indicate that replacement of cysteine-543
with a tyrosine residue in the cytoplasmic tail allows this protein
to assemble into coated pits and undergo endocytosis (Lazarovits
& Roth, 1988). whereas the native protein is excluded from
plasma-membrane coated pits (Roth et al., 1986). Substitution of
cysteine-543 with phenylalanine did not allow the HA protein to
rapidly internalize (Lazarovits & Roth, 1988). The effect of
replacement of tyrosine with cysteine or phenylalanine in the
recombinant HA protein is therefore more similar to the observ-
ations made with the transferrin receptor (Fig. 2) than with the
LDL receptor (Davis et al., 1987a). The difference observed for
the effects of substitution of tyrosine residues with cysteine and
phenylalanine between the LDL receptor and the transferrin
receptor suggests that tyrosine forms only a part of a recognition
domain that is required for endocytosis. Consistent with this
hypothesis is the finding that the location of the tyrosine residue
in the short cytoplasmic tail of the HA protein is critical for rapid
endocytosis (Lazarovits & Roth, 1988).
It has been previously demonstrated that the protein kinase C
phosphorylation site on the transferrin receptor, namely serine-
24 (Davis et al., 1986), is not required for receptor-mediated
endocytosis of diferric transferrin (Davis & Meisner, 1987;
Rothenberger et al., 1987; Zerial et al., 1987; McGraw et al.,
1988). The present study indicates a role for tyrosine-20 during
transferrin-receptor endocytosis. It is possible that tyrosine-20
forms part of a recognition domain that allows transferrin-
receptor endocytosis, but further work is required to identify this
structure. A goal for future studies will be to define the function
of receptor structures that are required for endocytosis. Recently,
the binding of the cytoplasmic domains of receptors to the
HA-IT adaptors of plasma-membrane coated vesicles has been
reported (Pearse, 1988; Glickman et al., 1989). It is possible
that this binding of receptors to HA-II adaptors may represent
an initial step in the pathway of endocytosis.
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